The American Society of Clinical Oncology annual meetings consistently provide revelations that shape our industry not just for the next year but for the decade and beyond. That’s why we’re pleased to announce members of our TD2 team will be attending this year’s event from May 29 through June 2 at McCormick Place in Chicago.
Led by a seasoned drug development team, TD2 provides a full spectrum of non-clinical, clinical and regulatory support to get your drug to patients at an expedited place. We hope to discuss your needs and the options we provide at any point during the conference.
For additional details, please contact VP of Sales Marc Appelbaum at firstname.lastname@example.org.
We look forward to meeting you and changing the way you think about the drug development process.
May 29, 2020